Thomas Jefferson University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Thomas Jefferson University sits in the top decile of US sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count).
Thomas Jefferson University: 292 sponsored US clinical trials, 54 recruiting.
Thomas Jefferson University sponsors 292 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 182 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Malignant Solid Neoplasm, with 4 trials.
Top-decile sponsor footprint
Thomas Jefferson University ranks in the top decile of sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
182 of 210 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
292 total, page 5 of 6
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients
NCT02389062
A Randomized Clinical Trial Evaluating Negative Pressure Therapy to Decrease Vascular Groin Incision Complications
NCT02581904
Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra
NCT02270918
Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
NCT02271165
Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
NCT02272244
Improving Medication Adherence in Older African Americans With Diabetes
NCT02174562
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
NCT02121340
Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
NCT02156583
Incobotulinum Toxin for the Treatment of Trigeminal Neuralgia
NCT02088632
Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
NCT02445651
Randomized Control Trial of Second Stage of Labor
NCT02101515
Intrathecal Hydromorphone for Cesarean Section
NCT02067520
Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center
NCT01944462
Pulsed Dye Laser Treatment of Onychomycosis
NCT01915355
Genecept Assay and Adverse Effects of Antidepressants
NCT02883660
Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?
NCT01856127
Transvaginal Ultrasound Training for Obstetrics and Gynecology Residents
NCT02890914
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
NCT01754987
Zoledronic Acid in Acute Spinal Cord Injury
NCT01642901
Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines
NCT01671410
How the Elderly Live With Pain in Heart Failure
NCT01794728
A Study Comparing Two Methods of Placing an Interscalene Nerve Catheter for Postoperative Pain Control in Patients Who Undergo Open Shoulder Surgery.
NCT01696188
STOPAIN in the Treatment of a Single Migraine Attack
NCT01687101
The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy
NCT01876576
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G)
NCT01588717
Use of a Functional Neuroimaging Battery for the Evaluation of a Meditation Retreat
NCT02443766
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
NCT01550510
Quantitative Subharmonic Breast Imaging
NCT01490892
Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome
NCT01452789
SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
NCT01473004
Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
NCT01555489
Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure
NCT01499134
Evaluation of Above the Cuff Suctioning During General Anesthesia
NCT01386879
Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment
NCT01299766
Pilot Study to Collect and Evaluate Data on the Use of IV* Ibuprofen in the Treatment of an Acute Migraine Attack
NCT01230411
Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters
NCT01357408
A Study of Sternal Closure After Open Heart Surgery: Rigid Versus Wire Closure
NCT01317095
The Effects of Two Functional Electrical Stimulation Cycling Paradigms
NCT01244594
Cesarean Trial of Staples vs. Sutures
NCT01211600
Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS
NCT01299779
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
NCT01012414
The Effects of Moviprep With Simethicone on Colonic Bubbles
NCT01209806
Low Vision Depression Prevention Trial for Age Related Macular Degeneration
NCT00769015
Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?
NCT00880425
Intravenous Exenatide (Byetta) During Surgery
NCT00882050
Comparing Two Different Ways to Take MoviPrep® Before Colonoscopy
NCT00929916
Beat the Blues: Treating Depression in African American Elders
NCT00511680
A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache
NCT00443352
A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting
NCT00440232
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin
NCT00449683
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 39 |
| Phase 2 | 34 |
| Phase 3 | 19 |
| Phase 4 | 27 |
What is open in the Thomas Jefferson University pipeline
54 recruiting of 292 indexed (18% open); 182 completed (62%).
Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).
Top condition: Malignant Solid Neoplasm (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Thomas Jefferson University: open-pipeline peers nationwide
Peers matched on 292 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Thomas Jefferson University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 292 trials (± recruiting share)
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- University of Missouri-Columbia · 291 trials · 19% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Florida Atlantic University · 19% recruiting · 27 trials
- Institut de Recherches Internationales Servier · 19% recruiting · 27 trials
- Natera · 19% recruiting · 27 trials
- Nemours Children's Clinic · 19% recruiting · 108 trials
Related
What to do with this Thomas Jefferson University page
292 registered trials is a research-attention snapshot, not an endorsement of Thomas Jefferson University or any single study.
- 54 of Thomas Jefferson University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Malignant Solid Neoplasm is the condition Thomas Jefferson University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Malignant Solid Neoplasm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Thomas Jefferson University pipeline card: 292 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.